FDA approves Bristol Myers, Pfizer's anti-clotting drug Eliquis
(Reuters) - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb Co and Pfizer Inc, for treatment in patients with atrial fibrillation, or irregular heartbeats. The drug, also known as apixaban, was approved by European health regulators last month. Eliquis belongs to a new class of medicines designed to replace decades-old warfarin for preventing blood clots in heart patients, or after a hip- or knee-replacement surgery. ...
Source: news.yahoo.com
No comments:
Post a Comment